A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 205 participants.
Also called NCT03951805
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 205 participants
- Sponsor
- Registry
-
NCT03951805 -
2018-003406-11
-
- Other papers using this trial's data
- A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Croatia, Germany, Hungary, Poland, Slovakia, Spain
- Registry status
- Completed
Technical summary
Registry record NCT03951805. Randomized; no masking; primary purpose treatment. Start 2019-05-09 (actual); primary completion 2019-12-12 (actual). Results posted on 2021-01-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Insulin icodec
- Intervention (Drug)
- Insulin Glargine
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct03951805- Content hash
64292bf0e2864a1b356d4d8ffe0be3853a60369386969c4e9419ac1253c6fbe2